• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6基因中-174 G/C基因多态性与侵袭性乳腺癌表型相关。

The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype.

作者信息

Iacopetta B, Grieu F, Joseph D

机构信息

School of Surgery and Pathology, University of Western Australia, Nedlands 6009, Australia.

出版信息

Br J Cancer. 2004 Jan 26;90(2):419-22. doi: 10.1038/sj.bjc.6601545.

DOI:10.1038/sj.bjc.6601545
PMID:14735187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409577/
Abstract

Serum and tissue levels of interleukin-6 (IL-6) have been implicated in the biological phenotype of breast carcinoma. A common G/C polymorphism at position -174 of the IL-6 promoter can influence the expression level of this gene. We therefore investigated for associations between this polymorphism and various phenotypic features in a series of 256 breast cancers. Individuals who were homozygous for the C allele (n=55) were more likely to have higher-grade tumours (P=0.039) with ductal histology (P=0.030) compared to those harbouring at least one wild-type G allele (n=201). Homozygosity for the C allele was also associated with significantly worse overall survival (P=0.031). We conclude that the -174 C allele of IL-6 is associated with a more aggressive breast cancer phenotype.

摘要

白细胞介素-6(IL-6)的血清和组织水平与乳腺癌的生物学表型有关。IL-6启动子-174位常见的G/C多态性可影响该基因的表达水平。因此,我们在256例乳腺癌患者中研究了这种多态性与各种表型特征之间的关联。与至少携带一个野生型G等位基因的个体(n = 201)相比,C等位基因纯合子个体(n = 55)更有可能患有组织学类型为导管癌的高级别肿瘤(P = 0.039)(P = 0.030)。C等位基因纯合性也与总体生存率显著较差相关(P = 0.031)。我们得出结论,IL-6的-174 C等位基因与更具侵袭性的乳腺癌表型相关。

相似文献

1
The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype.白细胞介素-6基因中-174 G/C基因多态性与侵袭性乳腺癌表型相关。
Br J Cancer. 2004 Jan 26;90(2):419-22. doi: 10.1038/sj.bjc.6601545.
2
Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.促炎细胞因子(白细胞介素-1β、白细胞介素-1α和白细胞介素-6)的基因变异与乳腺癌的侵袭性形式、生存率及复发预测相关。
Eur Cytokine Netw. 2005 Dec;16(4):253-60.
3
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.白细胞介素-6 -174G→C多态性与高危乳腺癌患者较好的预后相关。
Cancer Res. 2003 Nov 15;63(22):8051-6.
4
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.IL-8 和 CXCR2 基因多态性对乳腺癌易感性和侵袭性的联合作用。
BMC Cancer. 2010 Jun 12;10:283. doi: 10.1186/1471-2407-10-283.
5
Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.基质金属蛋白酶-2和基质金属蛋白酶-9基因的遗传多态性与乳腺癌表型
Breast Cancer Res Treat. 2004 Dec;88(3):197-204. doi: 10.1007/s10549-004-0595-6.
6
Interleukin 6 G-174 C polymorphism and breast cancer risk.白细胞介素6基因G-174C多态性与乳腺癌风险
Eur J Epidemiol. 2006;21(5):373-6. doi: 10.1007/s10654-006-9005-1. Epub 2006 May 23.
7
An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Cancer Res. 2003 Jun 15;63(12):3066-8.
8
Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.-174位白细胞介素6启动子多态性、血清白细胞介素6水平与风湿性多肌痛复发/再发风险之间的关系
J Rheumatol. 2006 Apr;33(4):703-8.
9
Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.白细胞介素-6基因启动子的分子筛查及-174G/C多态性对乳腺癌的影响
Cytokine. 2009 Sep;47(3):214-23. doi: 10.1016/j.cyto.2009.06.011. Epub 2009 Jul 28.
10
Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.白细胞介素-1β、白细胞介素-6 和白细胞介素-10 基因的多态性变异、它们的循环血清水平与印度女性乳腺癌风险的相关性研究。
Cytokine. 2012 Oct;60(1):122-8. doi: 10.1016/j.cyto.2012.06.241. Epub 2012 Jul 18.

引用本文的文献

1
The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.白细胞介素6样细胞因子家族:在乳腺癌中的作用及作为生物标志物的潜力
J Pers Med. 2021 Oct 24;11(11):1073. doi: 10.3390/jpm11111073.
2
STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.STAT3 多态性和 IL-6 多态性与波兰北部患者基底细胞癌的风险相关。
Arch Dermatol Res. 2019 Nov;311(9):697-704. doi: 10.1007/s00403-019-01952-7. Epub 2019 Jul 24.
3
Genetic Modifiers of the Breast Tumor Microenvironment.

本文引用的文献

1
Development of a rapid genotyping method for single nucleotide polymorphisms and its application in cancer studies.一种用于单核苷酸多态性的快速基因分型方法的开发及其在癌症研究中的应用。
Oncol Rep. 2004 Feb;11(2):501-4.
2
Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population.白细胞介素-6等位基因变体与澳大利亚社区人群亚临床颈动脉粥样硬化的关联。
Eur Heart J. 2003 Aug;24(16):1494-9. doi: 10.1016/s0195-668x(03)00313-0.
3
Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.
乳腺肿瘤微环境的遗传修饰因子
Trends Cancer. 2018 Jun;4(6):429-444. doi: 10.1016/j.trecan.2018.04.003. Epub 2018 May 8.
4
Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis.白细胞介素-6启动子基因多态性与癌症易感性及预后的关系:一项荟萃分析
Oncotarget. 2018 Jan 5;9(15):12351-12364. doi: 10.18632/oncotarget.24033. eCollection 2018 Feb 23.
5
Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.白细胞介素-6基因启动子-174G>C多态性与癌症患者的预后
Oncotarget. 2017 Jul 4;8(27):44490-44497. doi: 10.18632/oncotarget.17771.
6
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.白细胞介素-6 是白细胞介素-6 依赖性、雌激素受体-α阳性乳腺癌的潜在治疗靶点。
Breast Cancer (Dove Med Press). 2016 Feb 3;8:13-27. doi: 10.2147/BCTT.S92414. eCollection 2016.
7
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.在一个前瞻性乳腺癌队列中,白细胞介素6基因型、肿瘤雌激素受体状态及治疗可预测无病生存期。
BMC Cancer. 2014 Oct 11;14:759. doi: 10.1186/1471-2407-14-759.
8
Genetic modifiers of cancer risk in Lynch syndrome: a review.林奇综合征中癌症风险的遗传修饰物:综述。
Fam Cancer. 2013 Jun;12(2):207-16. doi: 10.1007/s10689-013-9614-2.
9
Interleukin-6 and the IL-6 (-174) C/G polymorphism in breast pathologies and in HIV-infected patients.白细胞介素 6 及其-174C/G 多态性与乳腺病变及 HIV 感染患者的相关性。
Arch Med Sci. 2010 Dec;6(6):860-5. doi: 10.5114/aoms.2010.19292. Epub 2010 Dec 29.
10
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.促炎细胞因子 IL6、IL6R、TNF 区域和 TNFRSF1A 中的遗传变异与乳腺癌风险。
Breast Cancer Res Treat. 2011 Oct;129(3):887-99. doi: 10.1007/s10549-011-1520-4. Epub 2011 Apr 27.
炎症基因白细胞介素(IL)6、IL8、肿瘤坏死因子α、NFKB1和过氧化物酶体增殖物激活受体γ中的常见多态性与结直肠癌的关联。
Cancer Res. 2003 Jul 1;63(13):3560-6.
4
An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Cancer Res. 2003 Jun 15;63(12):3066-8.
5
-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.白细胞介素6基因启动子-174 G>C多态性影响结直肠癌患者血清白细胞介素6水平。
Clin Cancer Res. 2003 Jun;9(6):2173-6.
6
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.白细胞介素6血清水平以及血管内皮生长因子血清和血浆水平在激素难治性转移性乳腺癌患者中的预后价值
Br J Cancer. 2003 Jun 2;88(11):1721-6. doi: 10.1038/sj.bjc.6600956.
7
Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset.促黄体生成素信号传导与乳腺癌:多态性与发病年龄
J Clin Endocrinol Metab. 2003 Apr;88(4):1653-7. doi: 10.1210/jc.2002-021585.
8
Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients.黑色素瘤患者白细胞介素-10、白细胞介素-6和干扰素-γ基因多态性
Melanoma Res. 2002 Oct;12(5):465-9. doi: 10.1097/00008390-200209000-00008.
9
IL-6 in autoimmune disease and chronic inflammatory proliferative disease.白细胞介素-6在自身免疫性疾病和慢性炎症增殖性疾病中的作用
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):357-68. doi: 10.1016/s1359-6101(02)00027-8.
10
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.白细胞介素-6基因启动子多态性的基因型与血浆C反应蛋白的基线水平相关。
Cardiovasc Res. 2002 Mar;53(4):1029-34. doi: 10.1016/s0008-6363(01)00534-x.